Cetera Advisors LLC Clovis Oncology, Inc. Transaction History

Cetera Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$1.05 - $2.85 $6,300 - $17,100	6,000 Added 58.08%	16,330 $19,000
Q2 2022 Aug 11, 2022	BUY	$0.63 - $2.96 $6,507 - $30,576	10,330 New	10,330 $19,000
Q1 2022 May 12, 2022	SELL	$1.43 - $3.14 $20,062 - $44,054	-14,030 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.76 $37,881 - $66,782	14,030 New	14,030 $38,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.